298 related articles for article (PubMed ID: 15744304)
1. Cross-presentation by intercellular peptide transfer through gap junctions.
Neijssen J; Herberts C; Drijfhout JW; Reits E; Janssen L; Neefjes J
Nature; 2005 Mar; 434(7029):83-8. PubMed ID: 15744304
[TBL] [Abstract][Full Text] [Related]
2. Coupling and cross-presentation.
Heath WR; Carbone FR
Nature; 2005 Mar; 434(7029):27-8. PubMed ID: 15744280
[No Abstract] [Full Text] [Related]
3. Direct antigen presentation and gap junction mediated cross-presentation during apoptosis.
Pang B; Neijssen J; Qiao X; Janssen L; Janssen H; Lippuner C; Neefjes J
J Immunol; 2009 Jul; 183(2):1083-90. PubMed ID: 19553546
[TBL] [Abstract][Full Text] [Related]
4. Information sharing and collateral damage.
Li G; Herlyn M
Trends Mol Med; 2005 Aug; 11(8):350-2. PubMed ID: 16002338
[TBL] [Abstract][Full Text] [Related]
5. Cross-presentation: underlying mechanisms and role in immune surveillance.
Rock KL; Shen L
Immunol Rev; 2005 Oct; 207():166-83. PubMed ID: 16181335
[TBL] [Abstract][Full Text] [Related]
6. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs.
Albert ML; Sauter B; Bhardwaj N
Nature; 1998 Mar; 392(6671):86-9. PubMed ID: 9510252
[TBL] [Abstract][Full Text] [Related]
7. Peptide-beta2-microglobulin-major histocompatibility complex expressing cells are potent antigen-presenting cells that can generate specific T cells.
Obermann S; Petrykowska S; Manns MP; Korangy F; Greten TF
Immunology; 2007 Sep; 122(1):90-7. PubMed ID: 17472719
[TBL] [Abstract][Full Text] [Related]
8. Factors affecting the presentation of exogenous hepatitis B virus core antigen.
Devasahayam M
Indian J Exp Biol; 2007 Aug; 45(8):689-95. PubMed ID: 17877145
[TBL] [Abstract][Full Text] [Related]
9. Efficiency of peptide presentation by dendritic cells compared with other cell types: implications for cross-priming.
Zehn D; Cohen CJ; Reiter Y; Walden P
Int Immunol; 2006 Dec; 18(12):1647-54. PubMed ID: 17035346
[TBL] [Abstract][Full Text] [Related]
10. RPE cells resist bystander killing by CTLs, but are highly susceptible to antigen-dependent CTL killing.
Gregerson DS; Lew KL; McPherson SW; Heuss ND; Ferrington DA
Invest Ophthalmol Vis Sci; 2006 Dec; 47(12):5385-94. PubMed ID: 17122128
[TBL] [Abstract][Full Text] [Related]
11. Priming of T cells by exogenous antigen cross-presented on MHC class I molecules.
Shen L; Rock KL
Curr Opin Immunol; 2006 Feb; 18(1):85-91. PubMed ID: 16326087
[TBL] [Abstract][Full Text] [Related]
12. Gap junctions at the dendritic cell-T cell interface are key elements for antigen-dependent T cell activation.
Elgueta R; Tobar JA; Shoji KF; De Calisto J; Kalergis AM; Bono MR; Rosemblatt M; Sáez JC
J Immunol; 2009 Jul; 183(1):277-84. PubMed ID: 19542439
[TBL] [Abstract][Full Text] [Related]
13. Efficient presentation of naturally processed HLA class I peptides by artificial antigen-presenting cells for the generation of effective antitumor responses.
Hirano N; Butler MO; Xia Z; Berezovskaya A; Murray AP; Ansén S; Nadler LM
Clin Cancer Res; 2006 May; 12(10):2967-75. PubMed ID: 16707591
[TBL] [Abstract][Full Text] [Related]
14. Antigen presentation. Naturally processed peptides.
Elliott T; Townsend A; Cerundolo V
Nature; 1990 Nov; 348(6298):195-7. PubMed ID: 2172837
[No Abstract] [Full Text] [Related]
15. Cellular protein is the source of cross-priming antigen in vivo.
Shen L; Rock KL
Proc Natl Acad Sci U S A; 2004 Mar; 101(9):3035-40. PubMed ID: 14978273
[TBL] [Abstract][Full Text] [Related]
16. The antigen self-presentation function of the cytotoxic T-cell clone 10BK.1 depends on reciprocal peptide presentation.
Staege MS; Dick T; Ertl R; Jahnel U; Nawrath H; Rammensee HG; Reske-Kunz AB
Immunology; 1994 Mar; 81(3):333-7. PubMed ID: 8206506
[TBL] [Abstract][Full Text] [Related]
17. Gap junction-mediated intercellular communication in the immune system.
Neijssen J; Pang B; Neefjes J
Prog Biophys Mol Biol; 2007; 94(1-2):207-18. PubMed ID: 17467043
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of MHC class I-restricted antigen processing and cross-presentation.
Cresswell P; Ackerman AL; Giodini A; Peaper DR; Wearsch PA
Immunol Rev; 2005 Oct; 207():145-57. PubMed ID: 16181333
[TBL] [Abstract][Full Text] [Related]
19. Preferential binding of unusually long peptides to MHC class I and its influence on the selection of target peptides for T cell recognition.
Burrows JM; Bell MJ; Brennan R; Miles JJ; Khanna R; Burrows SR
Mol Immunol; 2008 Mar; 45(6):1818-24. PubMed ID: 17981331
[TBL] [Abstract][Full Text] [Related]
20. The cross-priming pathway: a portrait of an intricate immune system.
Basta S; Alatery A
Scand J Immunol; 2007 Apr; 65(4):311-9. PubMed ID: 17386021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
